Elekta Overview
- Year Founded
-
1972
- Status
-
Public
- Employees
-
3,996
- Stock Symbol
-
EKTA B
- Investments
-
25
- Share Price
-
$6.22
- (As of Friday Closing)
Elekta General Information
Description
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 27%; Europe, the Middle East, and Africa accounting for 40%; and the Asia-Pacific contributing the remainder.
Contact Information
Website
www.elekta.comCorporate Office
- Hagaplan 4
- 113 68 Stockholm
- Sweden
Corporate Office
- Hagaplan 4
- 113 68 Stockholm
- Sweden
Elekta Stock Performance
As of 13-Nov-2026, Elekta’s stock price is $6.22. Its current market cap is $2.38B with 382M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.22 | $6.18 | $4.39 - $7.23 | $2.38B | 382M | 1.31M | -$0.10 |
Elekta Financials Summary
As of 31-Jul-2026, Elekta has a trailing 12-month revenue of $1.77B.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2026 30-Apr-2026 | FY 2025 30-Apr-2025 | FY 2024 30-Apr-2024 |
|---|---|---|---|---|
| EV | 2,378,628 | 2,699,267 | 2,491,181 | 3,203,821 |
| Revenue | 1,771,816 | 1,778,766 | 1,704,347 | 1,702,541 |
| EBITDA | 177,960 | 142,148 | 199,988 | 289,974 |
| Net Income | (38,622) | (55,221) | 22,421 | 122,342 |
| Total Assets | 2,795,794 | 2,895,072 | 3,001,902 | 2,870,883 |
| Total Debt | 715,742 | 787,378 | 783,911 | 662,406 |
Elekta Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Elekta Comparisons
Industry
Financing
Details
Elekta Competitors (10)
One of Elekta’s 10 competitors is Stryker, a Formerly VC-backed company based in Portage, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Stryker | Formerly VC-backed | Portage, MI | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| Apyx Medical | Corporation | Clearwater, FL | ||||
| Siemens Healthineers | Corporation | Forchheim, Germany |
Elekta Patents
Elekta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202508799-D0 | A support device | Pending | 04-Jun-2025 | ||
| WO-2026231126-A1 | Systems, methods, apparatuses relating to treatment planning | Pending | 01-May-2025 | ||
| GB-202506469-D0 | Radiotherapy treatment planning | Pending | 29-Apr-2025 | ||
| WO-2026229241-A1 | Radiotherapy treatment planning | Pending | 29-Apr-2025 | ||
| GB-202505955-D0 | Apparatus for controlling beam shape | Pending | 22-Apr-2025 |
Elekta Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Elekta Investments & Acquisitions (25)
Elekta’s most recent deal was a Corporate Asset Purchase with Philips Healthcare (Pinnacle Treatment Planning System Patent Portfolio). The deal was made on 03-May-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Philips Healthcare (Pinnacle Treatment Planning System Patent Portfolio) | 03-May-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Xoft | 22-Oct-2023 | Merger/Acquisition | Other Devices and Supplies | ||
| Joint Venture (Elekta / Sinopharm Group) | 07-Sep-2023 | Joint Venture | Medical Supplies | ||
| Premier Business Inter | 12-Feb-2023 | Merger/Acquisition | Distributors (Healthcare) | ||
| Özyürek Mümessillik ve Dış Ticaret | 02-Sep-2021 | Merger/Acquisition | Clinics/Outpatient Services |
Elekta ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Elekta Exits (3)
Elekta’s most recent exit was on 05-Dec-2019 from ViewRay. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| ViewRay | 05-Dec-2019 | Completed |
|
||
| Medical Intelligence Medizintechnik | 30-Nov-2005 | Completed |
|
||
| ONCOlog Medical | Later Stage VC | Completed |
Elekta Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ProKnow | Sanford, FL | 2016 | |
| CliniCast | Millbrae, CA | 2011 | |
| Elekta Ltee | Montreal, Canada | 2010 | |
| Premier Business Inter | Bangkok, Thailand | 2001 | |
| Sociedade Avanço | Algueirão-Mem Martins, Portugal | 1936 |
Elekta FAQs
-
When was Elekta founded?
Elekta was founded in 1972.
-
Where is Elekta headquartered?
Elekta is headquartered in Stockholm, Sweden.
-
What is the size of Elekta?
Elekta has 3,996 total employees.
-
What industry is Elekta in?
Elekta’s primary industry is Diagnostic Equipment.
-
Is Elekta a private or public company?
Elekta is a Public company.
-
What is Elekta’s stock symbol?
The ticker symbol for Elekta is EKTA B.
-
What is the current stock price of Elekta?
As of 13-Nov-2026 the stock price of Elekta is $6.22.
-
What is the current market cap of Elekta?
The current market capitalization of Elekta is $2.38B.
-
What is Elekta’s current revenue?
The trailing twelve month revenue for Elekta is $1.77B.
-
Who are Elekta’s competitors?
Stryker, Medtronic, Zimmer Biomet Holdings, Apyx Medical, and Siemens Healthineers are some of the 10 competitors of Elekta.
-
What is Elekta’s annual earnings per share (EPS)?
Elekta’s EPS for 12 months was -$0.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
